Breandán N Kennedy Selected Research

Breandán N Kennedy Research Topics

Disease

10	Neoplasms (Cancer) 02/2022 - 04/2009
5	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 04/2009
5	Blindness (Hysterical Blindness) 01/2020 - 02/2003
5	Retinal Degeneration 01/2020 - 01/2016
3	Adenocarcinoma 01/2020 - 02/2019
3	Eye Diseases (Eye Disease) 11/2016 - 11/2009
2	Uveal melanoma 02/2022 - 10/2020
2	Retinal Diseases 10/2017 - 01/2010
2	Microphthalmos 09/2014 - 06/2004
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Hemangioblastoma 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2020
1	Psoriatic Arthritis 09/2019
1	Inflammation (Inflammations) 09/2018
1	Hypopigmentation (Hypomelanosis) 12/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Cone-Rod Dystrophies 12/2016
1	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 12/2016
1	Infections 10/2016
1	Retinal Neovascularization 04/2016
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2016
1	Anophthalmos (Anophthalmia) 09/2014
1	Toxic Optic Neuropathy 01/2014
1	Poisoning 11/2011
1	Ganglion Cysts (Ganglion) 04/2011
1	Vision Disorders (Hemeralopia) 01/2010
1	Disease Progression 04/2009
1	Photophobia (Light Sensitivity) 09/2008
1	Achromatopsia 2 04/2008
1	Color Vision Defects (Color Blindness) 02/2007

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 01/2020 - 02/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2008
4	Pharmaceutical PreparationsIBA 10/2020 - 04/2009
3	Histone Deacetylase InhibitorsIBA 02/2022 - 01/2016
3	quininibIBA 10/2020 - 10/2016
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 12/2017
2	Bevacizumab (Avastin)FDA Link 10/2020 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 10/2016
1	ricolinostatIBA 02/2022
1	Microphthalmia-Associated Transcription FactorIBA 02/2022
1	ProteomeIBA 02/2022
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2020
1	AS 8IBA 10/2020
1	Conditioned Culture MediaIBA 10/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Histone Deacetylase 6IBA 01/2020
1	Phenol (Carbolic Acid)FDA Link 10/2019
1	PyrazinesIBA 10/2019
1	MicroRNAs (MicroRNA)IBA 09/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2019
1	Cisplatin (Platino)FDA LinkGeneric 02/2019
1	CytokinesIBA 09/2018
1	AdipokinesIBA 09/2018
1	Coloring Agents (Dyes)IBA 12/2017
1	tubastatin AIBA 01/2017
1	PeroxiredoxinsIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Dyneins (Dynein)IBA 12/2016
1	Monomeric GTP-Binding ProteinsIBA 12/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	cysteinyl-leukotrieneIBA 01/2016
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2016
1	Transcription Factors (Transcription Factor)IBA 09/2014
1	RetinoidsIBA 09/2014
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2011
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 11/2009
1	Retinal Pigments (Pigments, Visual)IBA 09/2008
1	OpsinsIBA 09/2008
1	TransducinIBA 02/2007
1	MorpholinosIBA 06/2004
1	Carrier Proteins (Binding Protein)IBA 02/2003

Therapy/Procedure

1	Neoadjuvant Therapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 10/2017
1	Intraocular Injections 10/2016